1. Home
  2. PVLA vs WALD Comparison

PVLA vs WALD Comparison

Compare PVLA & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • WALD
  • Stock Information
  • Founded
  • PVLA 2015
  • WALD 1988
  • Country
  • PVLA United States
  • WALD United States
  • Employees
  • PVLA N/A
  • WALD N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • WALD Package Goods/Cosmetics
  • Sector
  • PVLA Health Care
  • WALD Consumer Discretionary
  • Exchange
  • PVLA Nasdaq
  • WALD Nasdaq
  • Market Cap
  • PVLA 285.2M
  • WALD 306.3M
  • IPO Year
  • PVLA N/A
  • WALD 2021
  • Fundamental
  • Price
  • PVLA $53.42
  • WALD $1.73
  • Analyst Decision
  • PVLA Strong Buy
  • WALD Strong Buy
  • Analyst Count
  • PVLA 11
  • WALD 5
  • Target Price
  • PVLA $56.64
  • WALD $4.96
  • AVG Volume (30 Days)
  • PVLA 153.4K
  • WALD 477.4K
  • Earning Date
  • PVLA 08-14-2025
  • WALD 09-02-2025
  • Dividend Yield
  • PVLA N/A
  • WALD N/A
  • EPS Growth
  • PVLA N/A
  • WALD N/A
  • EPS
  • PVLA N/A
  • WALD N/A
  • Revenue
  • PVLA N/A
  • WALD $273,868,000.00
  • Revenue This Year
  • PVLA N/A
  • WALD $14.78
  • Revenue Next Year
  • PVLA N/A
  • WALD $15.84
  • P/E Ratio
  • PVLA N/A
  • WALD N/A
  • Revenue Growth
  • PVLA N/A
  • WALD 25.55
  • 52 Week Low
  • PVLA $11.17
  • WALD $1.50
  • 52 Week High
  • PVLA $53.93
  • WALD $4.74
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 85.86
  • WALD 40.76
  • Support Level
  • PVLA $46.08
  • WALD $1.50
  • Resistance Level
  • PVLA $50.22
  • WALD $1.98
  • Average True Range (ATR)
  • PVLA 3.11
  • WALD 0.16
  • MACD
  • PVLA 0.70
  • WALD 0.01
  • Stochastic Oscillator
  • PVLA 97.00
  • WALD 38.33

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: